RON tyrosine kinase mutations in brain metastases from lung cancer

RON tyrosine kinase mutations in brain metastases from lung cancer

Bibliographic Details
Main Authors:	Melissa Milan, Silvia Benvenuti, Alice Maria Balderacchi, Anna Rita Virzì, Alessandra Gentile, Rebecca Senetta, Paola Cassoni, Paolo Maria Comoglio, Giulia Maria Stella
Format:	Article
Language:	English
Published:	European Respiratory Society 2018-03-01
Series:	ERJ Open Research
Online Access:	http://openres.ersjournals.com/content/4/1/00083-2017.full

Similar Items

The Ron Receptor Tyrosine Kinase in Prostate Cancer
by: Thobe, Megan
Published: (2010)

The Ron Receptor Tyrosine Kinase in Tissue Morphogenesis
by: Meyer, Sara
Published: (2009)

Regulation of macrophage polarization by RON receptor tyrosine kinase signaling
by: Amitabha eChaudhuri
Published: (2014-10-01)

The role of the receptor tyrosine kinase RON in inhibiting HIV transcription
by: Cantor, Amanda
Published: (2015)

The Ron Receptor Tyrosine Kinase as a Mediator of Inflammation and Tumorigenesis
by: Paluch, Andrew M.
Published: (2016)

Expression of ron tyrosin kinase receptor on breast cancer cell lines
by: Alzeini, Khaled W. K.
Published: (2013)

The role of receptor tyrosine kinase RON in the response of cancer cells to cellular stress
by: Hong-YiChang, et al.
Published: (2014)

The Receptor Tyrosine Kinase RON and Its Isoforms as Therapeutic Targets in Ewing Sarcoma
by: Philipp Berning, et al.
Published: (2020-04-01)

The Role of RON Receptor Tyrosine Kinase in Influenza A Virus Life Cycle
by: Chieh Mei Ting, et al.
Published: (2013)

Significance of the entire C-terminus in biological activities mediated by the RON receptor tyrosine kinase and its oncogenic variant RON160
by: Yao Hang-Ping, et al.
Published: (2008-10-01)

Ron Receptor Tyrosine Kinase Activation Confers Resistance to Tamoxifen in Breast Cancer Cell Lines
by: Rebecca J. McClaine, et al.
Published: (2010-08-01)

Erratum to: Ockham’s razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer
by: Giulia M. Stella, et al.
Published: (2017-09-01)

Crystal structure of the Sema-PSI extracellular domain of human RON receptor tyrosine kinase.
by: Kinlin L Chao, et al.
Published: (2012-01-01)

Evidence for 2-Methoxyestradiol-Mediated Inhibition of Receptor Tyrosine Kinase RON in the Management of Prostate Cancer
by: Izhar Singh Batth, et al.
Published: (2021-02-01)

MicroRNA Expression Profiling of Lung Cancer with Differential Expression of the RON Receptor Tyrosine Kinase
by: Huilin Ou, et al.
Published: (2021-01-01)

Neuroprotective Role of the Ron Receptor Tyrosine Kinase Underlying Central Nervous System Inflammation in Health and Disease
by: Adwitia Dey, et al.
Published: (2018-03-01)

Expression of the RON receptor tyrosine kinase and its association with gastric carcinoma versus normal gastric tissues
by: Yian Liping, et al.
Published: (2008-11-01)

The RON Receptor Tyrosine Kinase Promotes Metastasis by Triggering MBD4-Dependent DNA Methylation Reprogramming
by: Stéphanie Cunha, et al.
Published: (2014-01-01)

MET Activation and Physical Dynamics of the Metastatic Process: The Paradigm of Cancers of Unknown Primary Origin
by: Giulia M. Stella, et al.
Published: (2017-10-01)

Cancers of unknown primary origin: current perspectives and future therapeutic strategies
by: Stella Giulia, et al.
Published: (2012-01-01)

RON receptor tyrosine kinase expression is decreased during simian immunodeficiency virus associated central nervous system disease
by: Cary, Daniele Catherine
Published: (2015)

MET and RON receptor tyrosine kinases in colorectal adenocarcinoma: molecular features as drug targets and antibody-drug conjugates for therapy
by: Hang-Ping Yao, et al.
Published: (2020-09-01)

Splice variants of the extracellular region of RON receptor tyrosine kinase in lung cancer cell lines identified by PCR and sequencing
by: Soundararajan Krishnaswamy, et al.
Published: (2017-11-01)

Role of the HGF/c-MET tyrosine kinase inhibitors in metastasic melanoma
by: Lucia Demkova, et al.
Published: (2018-02-01)

Targeting RON receptor tyrosine kinase for treatment of advanced solid cancers: antibody–drug conjugates as lead drug candidates for clinical trials
by: Hang-Ping Yao, et al.
Published: (2020-05-01)

Deletion or insertion in the first immunoglobulin-plexin-transcription (IPT) domain differentially regulates expression and tumorigenic activities of RON receptor Tyrosine Kinase
by: Wang Ming-Hai, et al.
Published: (2010-11-01)

Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Pancreatic Cancer
by: Chen-Yu Hu, et al.
Published: (2019-12-01)

Transformation and scattering activities of the receptor tyrosine kinase RON/Stk in rodent fibroblasts and lack of regulation by the jaagsiekte sheep retrovirus receptor, Hyal2
by: Miller A Dusty, et al.
Published: (2004-09-01)

Ribosomal Protein S6 Kinase (RSK)-2 as a central effector molecule in RON receptor tyrosine kinase mediated epithelial to mesenchymal transition induced by macrophage-stimulating protein
by: Zhang Rui-Wen, et al.
Published: (2011-05-01)

The monoclonal antibody Zt/f2 targeting RON receptor tyrosine kinase as potential therapeutics against tumor growth-mediated by colon cancer cells
by: Zhang Rui-Wen, et al.
Published: (2011-07-01)

Unwinding RON carry-trade or RON speculative attack?
by: Silviu Eduard Dincă
Published: (2013-11-01)

Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report
by: Silvia Benvenuti, et al.
Published: (2020-07-01)

Tyrosine Kinase Inhibitors as a Treatment of Symptomatic CNS Metastases in Oncogene-Driven NSCLC
by: Omer Gal, et al.
Published: (2020-01-01)

RON kinase isoforms demonstrate variable cell motility in normal cells
by: Alissa Greenbaum, et al.
Published: (2016-09-01)

Lung-Seeking Metastases
by: Giulia M. Stella, et al.
Published: (2019-07-01)

TYROSINE KINASE INHIBITORS AND INTERFERON
by: Maria Dimou, et al.
Published: (2014-01-01)

Ron Winkler
by: Daniel Bencomo
Published: (2013-01-01)

Ron knockdown and Ron monoclonal antibody IMC-RON8 sensitize pancreatic cancer to histone deacetylase inhibitors (HDACi).
by: Yi Zou, et al.
Published: (2013-01-01)

Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy
by: Hang-Ping Yao, et al.
Published: (2019-03-01)

Ron Boschma e Ron Martin - The Handbook of Evolutionary Economic Geography
by: Renato Garcia
Published: (2012-05-01)